These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1354750)

  • 21. Doxorubicin and the alkylating anthracycline 3'-deamino-3'-(3-cyano-4-morpholinyl) doxorubicin: comparative in vitro potency against leukemia and bone marrow cells.
    Beckman RA; McFall PJ; Sikic BI; Smith SD
    J Natl Cancer Inst; 1988 May; 80(5):361-5. PubMed ID: 3357201
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5'-[4-(Pivaloyloxy)-1,3,2-dioxaphosphorinan-2-yl]-2'-deoxy-5-fluorouridine: a membrane-permeating prodrug of 5-fluoro-2'-deoxyuridylic acid (FdUMP).
    Farquhar D; Chen R; Khan S
    J Med Chem; 1995 Feb; 38(3):488-95. PubMed ID: 7853342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [14-O-hemiesters and 13-hydrazones of anthracyline antibiotics of the daunorubicin series. Synthesis and cytostatic activity with respect to tumor cells sensitive or resistant to doxorubicin].
    Povarov LS; Leont'eva OV; Bernaki PD; Olsuf'eva EN; Salimova EI; Pera P; Preobrazhenskaia MN
    Bioorg Khim; 1995 Dec; 21(12):925-32. PubMed ID: 8602889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of cytotoxic luteinizing hormone-releasing hormone conjugate (AN-152) containing doxorubicin 14-O-hemiglutarate in mouse and human serum in vitro: implications for the design of preclinical studies.
    Nagy A; Plonowski A; Schally AV
    Proc Natl Acad Sci U S A; 2000 Jan; 97(2):829-34. PubMed ID: 10639165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensely cytotoxic anthracycline prodrugs: glucuronides.
    Bakina E; Wu Z; Rosenblum M; Farquhar D
    J Med Chem; 1997 Dec; 40(25):4013-8. PubMed ID: 9406592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accumulation of degradation products of doxorubicin and pirarubicin formed in cell culture medium within sensitive and resistant cells.
    Fiallo M; Laigle A; Borrel MN; Garnier-Suillerot A
    Biochem Pharmacol; 1993 Feb; 45(3):659-65. PubMed ID: 8095138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficient induction of apoptosis by doxorubicin coupled to cell-penetrating peptides compared to unconjugated doxorubicin in the human breast cancer cell line MDA-MB 231.
    Aroui S; Brahim S; De Waard M; Bréard J; Kenani A
    Cancer Lett; 2009 Nov; 285(1):28-38. PubMed ID: 19523755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
    Friche E; Demant EJ; Sehested M; Nissen NI
    Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis of poly[N-(2-hydroxypropyl)methacrylamide] conjugates of inhibitors of the ABC transporter that overcome multidrug resistance in doxorubicin-resistant P388 cells in vitro.
    Subr V; Sivák L; Koziolová E; Braunová A; Pechar M; Strohalm J; Kabešová M; Ríhová B; Ulbrich K; Kovář M
    Biomacromolecules; 2014 Aug; 15(8):3030-43. PubMed ID: 24978588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of doxorubicin resistance in multidrug-resistant cells by liposomes.
    Thierry AR; Vigé D; Coughlin SS; Belli JA; Dritschilo A; Rahman A
    FASEB J; 1993 Apr; 7(6):572-9. PubMed ID: 8097173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhancement of anthracycline growth inhibition in parent and multidrug-resistant Chinese hamster ovary cells by cyclosporin A and its analogues.
    Chambers SK; Hait WN; Kacinski BM; Keyes SR; Handschumacher RE
    Cancer Res; 1989 Nov; 49(22):6275-9. PubMed ID: 2804973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P-glycoprotein and alterations in the glutathione/glutathione-peroxidase cycle underlie doxorubicin resistance in HL-60-R, a subclone of the HL-60 human leukemia cell line.
    Raghu G; Pierre-Jerome M; Dordal MS; Simonian P; Bauer KD; Winter JN
    Int J Cancer; 1993 Mar; 53(5):804-11. PubMed ID: 8095491
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Doxorubicin analogues incorporating chemically reactive substituents.
    Farquhar D; Newman RA; Zuckerman JE; Andersson BS
    J Med Chem; 1991 Feb; 34(2):561-4. PubMed ID: 1995877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxorubicin coupled to penetratin promotes apoptosis in CHO cells by a mechanism involving c-Jun NH2-terminal kinase.
    Aroui S; Mili D; Brahim S; De Waard M; Kenani A
    Biochem Biophys Res Commun; 2010 Jun; 396(4):908-14. PubMed ID: 20457128
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxazolidine, a proposed active metabolite of doxorubicin that cross-links DNA.
    Post GC; Barthel BL; Burkhart DJ; Hagadorn JR; Koch TH
    J Med Chem; 2005 Dec; 48(24):7648-57. PubMed ID: 16302805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfection of a 4-hydroxynonenal metabolizing glutathione S-transferase isozyme, mouse GSTA4-4, confers doxorubicin resistance to Chinese hamster ovary cells.
    He NG; Singhal SS; Srivastava SK; Zimniak P; Awasthi YC; Awasthi S
    Arch Biochem Biophys; 1996 Sep; 333(1):214-20. PubMed ID: 8806773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for reversal of multidrug resistance by quinine in LR73 cells without alteration of nuclear pirarubicin uptake and down-regulation of mdr1 gene expression.
    Belhoussine R; Morjani H; Lahlil R; Manfait M
    Int J Cancer; 1997 Nov; 73(4):600-6. PubMed ID: 9389578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and characterization of a cell line resistant to 5-[3-(2-nitro-1-imidazoyl)-propyl]-phenanthridinium bromide (2-NLP-3), a DNA-intercalating hypoxic cell radiosensitizer and cytotoxin.
    Cowan DS; McClelland RA; Rauth AM
    Biochem Pharmacol; 1995 Jun; 50(1):61-8. PubMed ID: 7605346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.